Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer

ClinicalTrials.gov ID: NCT00006027

Public ClinicalTrials.gov record NCT00006027. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Study of Adjuvant Postoperative Irradiation With or Without Cisplatin/Taxol Chemotherapy Following TAH/BSO for Patients With Endometrial Cancer

Study identification

NCT ID
NCT00006027
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Radiation Therapy Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • cisplatin Drug
  • paclitaxel Drug
  • adjuvant therapy Procedure
  • radiation therapy Radiation

Drug · Procedure · Radiation

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2000
Primary completion
May 31, 2004
Completion
Not listed
Last update posted
Oct 21, 2020

Started 2000

United States locations

U.S. sites
28
U.S. states
20
U.S. cities
28
Facility City State ZIP Site status
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1740
Community Hospital of Los Gatos Los Gatos California 95032
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center Orange California 92868
University of Colorado Cancer Center at University of Colorado Health Sciences Center Denver Colorado 80010
MBCCOP - Hawaii Honolulu Hawaii 96813
Indiana University Cancer Center Indianapolis Indiana 46202-5289
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242-1009
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda Maryland 20892-1182
Tufts - New England Medical Center Boston Massachusetts 02111
University of Minnesota Cancer Center Minneapolis Minnesota 55455
University of Mississippi Medical Center Jackson Mississippi 39216-4505
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203
Cooper University Hospital Camden New Jersey 08103-1489
State University of New York Health Science Center at Brooklyn Brooklyn New York 11203
Memorial Sloan-Kettering Cancer Center New York New York 10021
Long Island Cancer Center at Stony Brook University Hospital Stony Brook New York 11794-8091
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295
Duke Comprehensive Cancer Center Durham North Carolina 27710
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1065
University of Oklahoma College of Medicine Oklahoma City Oklahoma 73190
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107-5541
Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina 29425-2233
Brookview Research, Inc. Nashville Tennessee 37203
University of Texas Medical Branch Galveston Texas 77555-0587
Fred Hutchinson Cancer Research Center Seattle Washington 98109-1024
Tacoma General Hospital Tacoma Washington 98405
CCOP - Marshfield Clinic Research Foundation Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 21, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006027 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →